Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF IL-19, IL-22 AND IL-24 TO TREAT HEMATOPOIETIC DISORDERS
Document Type and Number:
WIPO Patent Application WO2003089569
Kind Code:
A3
Abstract:
The present invention relates to a method of using a mammalian gene sequence and polypeptides encoded thereby to treat mammalian hematopoietic disorders.

More Like This:
WO/2010/103070BONE MORPHOGENETIC PROTEIN 2 (BMP2) VARIANTS WITH REDUCED BMP ANTAGONIST SENSITIVITY
WO/2002/094271TARGETED DELIVERY OF BIOAFFECTING COMPOUNDS FOR THE TREATMENT OF CANCER
WO/2004/022577LONG ACTING ERYTHROPOIETINS THAT MAINTAIN TISSUE PROTECTIVE ACTIVITY OF ENDOGENOUS ERYTHROPOIETIN
Inventors:
ROWLINSON SCOTT WILLIAM (US)
Application Number:
PCT/US2002/031599
Publication Date:
January 13, 2005
Filing Date:
October 24, 2002
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
LILLY CO ELI (US)
ROWLINSON SCOTT WILLIAM (US)
International Classes:
A61K38/18; A61K38/19; A61K38/00; A61K38/20; A61K39/395; A61P7/04; A61P7/06; A61P13/12; A61P17/02; A61P35/02; A61P35/04; A61P43/00; (IPC1-7): A61K38/19; A61K38/20
Foreign References:
US5985614A1999-11-16
Other References:
See also references of EP 1511511A4
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: METHOD OF INHIBITING RESTENOSIS

Next Patent: CRYSTALS AND STRUCTURES OF CMP-KDO SYNTHETASE KdoPS or CKS